Patients’ perceptions of self-administered dosing to opioid agonist treatment and other changes during the COVID-19 pandemic: a qualitative study
العنوان: | Patients’ perceptions of self-administered dosing to opioid agonist treatment and other changes during the COVID-19 pandemic: a qualitative study |
---|---|
المؤلفون: | Gemma Scott, Sophie Turner, Natalie Lowry, Annette Hodge, Waniya Ashraf, Katie McClean, Mike Kelleher, Luke Mitcheson, John Marsden |
المصدر: | BMJ Open. 13:e069857 |
بيانات النشر: | BMJ, 2023. |
سنة النشر: | 2023 |
مصطلحات موضوعية: | General Medicine |
الوصف: | ObjectivesDuring the COVID-19 pandemic, addiction treatment services received official guidance asking them to limit face-to-face contact with patients and to prescribe opioid agonist treatment (OAT) medication flexibly. With the aim for most patients to receive take-home supplies for self-administration rather than attendance for observed daily dosing.DesignThis was a theory-driven, clinically applied qualitative study, with data for thematic analysis collected by semi-structured, audio-recorded, telephone interviews.ParticipantsTwenty-seven adults (aged ≥18 years) enrolled in sublingual (tablet) buprenorphine and oral (liquid) methadone OAT.SettingCommunity addictions centre in the London Borough of Lambeth operated by South London and Maudsley NHS Trust.ResultsThree major themes were identified: (1) dissatisfaction and perceived stigma with OAT medication dispensing arrangements before the pandemic; (2) positive adaptations in response to COVID-19 by services; (3) participants recommended that, according to preference and evidence of adherence, OAT should be personalised to offer increasing medication supplies for self-administration from as early as 7 days after commencement of maintenance prescribing.ConclusionsIn an applied qualitative study of patients enrolled in OAT during the COVID-19 pandemic, participants endorsed their opportunity to take medication themselves at home and with virtual addiction support. Most patients described a preference for self-administration with increased dispensing supplies, from as early as 7 days into maintenance treatment, if they could demonstrate adherence to their prescription. |
تدمد: | 2044-6055 |
URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_________::fa758417080188b06fe875c2b9e022ea https://doi.org/10.1136/bmjopen-2022-069857 |
حقوق: | OPEN |
رقم الأكسشن: | edsair.doi...........fa758417080188b06fe875c2b9e022ea |
قاعدة البيانات: | OpenAIRE |
كن أول من يترك تعليقا!